This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (21)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

MATTHEW J. BRUNNER, M.D.; PAUL FINKELSTEIN, Ph.D.

AMA Arch Derm. 1960;81(3):453-457.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Introduction

Critical evaluation of the potency of topically applied steroids has been a difficult task. The method of evaluation most often used has been clinical trial in inflammatory dermatoses, using symmetrical sites for paired comparisons.^1-5 This technic is at best a tedious one, and is limited to the comparison of two treatments in each subject. It is difficult to find treatment sites which are exactly comparable, and large numbers of subjects must be used to obtain significant figures. The evaluation of the results of these clinical trials is not precise, and readings must be made by trained personnel. For example, with hydrocortisone, although clinical usage has long since established its usefulness, it may be difficult to distinguish this agent from a placebo in carefully controlled clinical trials.⁶ It is clear that an efficient laboratory method is needed to allow for rapid screening of topical anti-inflammatory activity of the . . . [Full Text PDF of this Article]

Author Affiliations
Chicago

Department of Dermatology, Northwestern University Medical School, and the Toni Company, Chicago (Dr. Brunner). The Toni Company, a Division of The Gillette Company, Chicago (Dr. Finkelstein).

Footnotes
Submitted for publication June 19, 1959.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?